Sg3 Management, LLC Corcept Therapeutics Inc Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $1.68 Million - $1.93 Million	-85,600 Reduced 69.54%	37,500 $738,000
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $1.86 Million - $2.27 Million	93,100 Added 310.33%	123,100 $2.71 Million
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $293,625 - $382,000	12,500 Added 71.43%	30,000 $714,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $125,850 - $204,750	-7,500 Reduced 30.0%	17,500 $458,000
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $311,500 - $499,500	25,000 New	25,000 $435,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.